Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management

Jayer Chung, Wilmer Valentine, Sherene E. Sharath, Amita Pathak, Neal R. Barshes, George Pisimisis, Panagiotis Kougias, Joseph L. Mills

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background The appropriateness of percutaneous intervention for moderate to severe carotid in-stent restenosis (C-ISR) is unclear. We therefore sought to compare stroke/death/myocardial infarction (MI) rates between percutaneous interventions and nonoperative management for ≥50% C-ISR. Methods We performed a single-center retrospective review of consecutive patients presenting with ≥50% C-ISR to the vascular surgery service. Demographics, comorbidities, and intraoperative and postoperative variables were obtained. The degree of stenosis was verified by review of digital subtraction or computed tomography angiograms. The primary outcome was stroke/death/MI after the diagnosis of ≥50% C-ISR. χ2, Kruskal-Wallis, and Kaplan-Meier analysis was used to quantify outcomes of the patients treated percutaneously vs nonoperatively. Results During a 13-year period, 59 patients (75 C-ISRs) presented with ≥50% C-ISRs (n = 58 male [98%]; n = 57 C-ISRs asymptomatic [76%]) with a median age of 67.5 years (62.8-74.6). The initial pathologic process underlying the original stent was atherosclerosis in 33 (70%), radiation induced in 10 (21%), prior carotid endarterectomy in 4 (9%), and unknown in 28 (37%). Forty C-ISRs underwent a percutaneous intervention (19 percutaneous angioplasty only [48%]; 21 repeated stent and percutaneous angioplasty [52%]). Median follow-up for the entire cohort was 948 days (283-2322) and similar between the intervention and nonintervention arms. There were no significant differences between the arms with respect to age (P =.16), medical comorbidities (P >.05), original stent type (P =.46), or clopidogrel use (P =.74). At 30 days, there was one stroke and subsequent death in the intervention arm and none in the nonintervention arm. During the follow-up period, a median of 1.0 procedure was required to maintain patency. By Kaplan-Meier analysis, there were no statistically significant differences between the intervention and nonintervention arms with respect to stroke/death/MI as a composite or any of the individual components at last follow-up (P =.82). Kaplan-Meier estimated patency was not significantly superior in the intervention vs the nonintervention arm (8.0 years ± 1.1 vs 5.3 years ± 0.7; P =.14). Conclusions Over 13 years, percutaneous interventions for ≥50% C-ISR were safe and durable. However, interventions fail to improve long-term stroke/death/MI or patency rates relative to nonintervention. Intervention for C-ISR may not be necessary, although future appropriately powered, prospective trials will be necessary to confirm these findings and to determine the appropriateness of interventions for C-ISR.

Original languageEnglish (US)
Pages (from-to)1286-1294.e1
JournalJournal of Vascular Surgery
Volume64
Issue number5
DOIs
StatePublished - Nov 1 2016

Fingerprint

Stents
Stroke
Myocardial Infarction
clopidogrel
Kaplan-Meier Estimate
Angioplasty
Comorbidity
Carotid Endarterectomy
Pathologic Processes
Blood Vessels
Atherosclerosis
Angiography
Pathologic Constriction
Tomography
Demography
Radiation

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Chung, J., Valentine, W., Sharath, S. E., Pathak, A., Barshes, N. R., Pisimisis, G., ... Mills, J. L. (2016). Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management. Journal of Vascular Surgery, 64(5), 1286-1294.e1. https://doi.org/10.1016/j.jvs.2016.05.086

Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management. / Chung, Jayer; Valentine, Wilmer; Sharath, Sherene E.; Pathak, Amita; Barshes, Neal R.; Pisimisis, George; Kougias, Panagiotis; Mills, Joseph L.

In: Journal of Vascular Surgery, Vol. 64, No. 5, 01.11.2016, p. 1286-1294.e1.

Research output: Contribution to journalArticle

Chung, J, Valentine, W, Sharath, SE, Pathak, A, Barshes, NR, Pisimisis, G, Kougias, P & Mills, JL 2016, 'Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management', Journal of Vascular Surgery, vol. 64, no. 5, pp. 1286-1294.e1. https://doi.org/10.1016/j.jvs.2016.05.086
Chung, Jayer ; Valentine, Wilmer ; Sharath, Sherene E. ; Pathak, Amita ; Barshes, Neal R. ; Pisimisis, George ; Kougias, Panagiotis ; Mills, Joseph L. / Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management. In: Journal of Vascular Surgery. 2016 ; Vol. 64, No. 5. pp. 1286-1294.e1.
@article{31d6bd53e2bd4715963d942e60946c93,
title = "Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management",
abstract = "Background The appropriateness of percutaneous intervention for moderate to severe carotid in-stent restenosis (C-ISR) is unclear. We therefore sought to compare stroke/death/myocardial infarction (MI) rates between percutaneous interventions and nonoperative management for ≥50{\%} C-ISR. Methods We performed a single-center retrospective review of consecutive patients presenting with ≥50{\%} C-ISR to the vascular surgery service. Demographics, comorbidities, and intraoperative and postoperative variables were obtained. The degree of stenosis was verified by review of digital subtraction or computed tomography angiograms. The primary outcome was stroke/death/MI after the diagnosis of ≥50{\%} C-ISR. χ2, Kruskal-Wallis, and Kaplan-Meier analysis was used to quantify outcomes of the patients treated percutaneously vs nonoperatively. Results During a 13-year period, 59 patients (75 C-ISRs) presented with ≥50{\%} C-ISRs (n = 58 male [98{\%}]; n = 57 C-ISRs asymptomatic [76{\%}]) with a median age of 67.5 years (62.8-74.6). The initial pathologic process underlying the original stent was atherosclerosis in 33 (70{\%}), radiation induced in 10 (21{\%}), prior carotid endarterectomy in 4 (9{\%}), and unknown in 28 (37{\%}). Forty C-ISRs underwent a percutaneous intervention (19 percutaneous angioplasty only [48{\%}]; 21 repeated stent and percutaneous angioplasty [52{\%}]). Median follow-up for the entire cohort was 948 days (283-2322) and similar between the intervention and nonintervention arms. There were no significant differences between the arms with respect to age (P =.16), medical comorbidities (P >.05), original stent type (P =.46), or clopidogrel use (P =.74). At 30 days, there was one stroke and subsequent death in the intervention arm and none in the nonintervention arm. During the follow-up period, a median of 1.0 procedure was required to maintain patency. By Kaplan-Meier analysis, there were no statistically significant differences between the intervention and nonintervention arms with respect to stroke/death/MI as a composite or any of the individual components at last follow-up (P =.82). Kaplan-Meier estimated patency was not significantly superior in the intervention vs the nonintervention arm (8.0 years ± 1.1 vs 5.3 years ± 0.7; P =.14). Conclusions Over 13 years, percutaneous interventions for ≥50{\%} C-ISR were safe and durable. However, interventions fail to improve long-term stroke/death/MI or patency rates relative to nonintervention. Intervention for C-ISR may not be necessary, although future appropriately powered, prospective trials will be necessary to confirm these findings and to determine the appropriateness of interventions for C-ISR.",
author = "Jayer Chung and Wilmer Valentine and Sharath, {Sherene E.} and Amita Pathak and Barshes, {Neal R.} and George Pisimisis and Panagiotis Kougias and Mills, {Joseph L.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.jvs.2016.05.086",
language = "English (US)",
volume = "64",
pages = "1286--1294.e1",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Percutaneous intervention for carotid in-stent restenosis does not improve outcomes compared with nonoperative management

AU - Chung, Jayer

AU - Valentine, Wilmer

AU - Sharath, Sherene E.

AU - Pathak, Amita

AU - Barshes, Neal R.

AU - Pisimisis, George

AU - Kougias, Panagiotis

AU - Mills, Joseph L.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background The appropriateness of percutaneous intervention for moderate to severe carotid in-stent restenosis (C-ISR) is unclear. We therefore sought to compare stroke/death/myocardial infarction (MI) rates between percutaneous interventions and nonoperative management for ≥50% C-ISR. Methods We performed a single-center retrospective review of consecutive patients presenting with ≥50% C-ISR to the vascular surgery service. Demographics, comorbidities, and intraoperative and postoperative variables were obtained. The degree of stenosis was verified by review of digital subtraction or computed tomography angiograms. The primary outcome was stroke/death/MI after the diagnosis of ≥50% C-ISR. χ2, Kruskal-Wallis, and Kaplan-Meier analysis was used to quantify outcomes of the patients treated percutaneously vs nonoperatively. Results During a 13-year period, 59 patients (75 C-ISRs) presented with ≥50% C-ISRs (n = 58 male [98%]; n = 57 C-ISRs asymptomatic [76%]) with a median age of 67.5 years (62.8-74.6). The initial pathologic process underlying the original stent was atherosclerosis in 33 (70%), radiation induced in 10 (21%), prior carotid endarterectomy in 4 (9%), and unknown in 28 (37%). Forty C-ISRs underwent a percutaneous intervention (19 percutaneous angioplasty only [48%]; 21 repeated stent and percutaneous angioplasty [52%]). Median follow-up for the entire cohort was 948 days (283-2322) and similar between the intervention and nonintervention arms. There were no significant differences between the arms with respect to age (P =.16), medical comorbidities (P >.05), original stent type (P =.46), or clopidogrel use (P =.74). At 30 days, there was one stroke and subsequent death in the intervention arm and none in the nonintervention arm. During the follow-up period, a median of 1.0 procedure was required to maintain patency. By Kaplan-Meier analysis, there were no statistically significant differences between the intervention and nonintervention arms with respect to stroke/death/MI as a composite or any of the individual components at last follow-up (P =.82). Kaplan-Meier estimated patency was not significantly superior in the intervention vs the nonintervention arm (8.0 years ± 1.1 vs 5.3 years ± 0.7; P =.14). Conclusions Over 13 years, percutaneous interventions for ≥50% C-ISR were safe and durable. However, interventions fail to improve long-term stroke/death/MI or patency rates relative to nonintervention. Intervention for C-ISR may not be necessary, although future appropriately powered, prospective trials will be necessary to confirm these findings and to determine the appropriateness of interventions for C-ISR.

AB - Background The appropriateness of percutaneous intervention for moderate to severe carotid in-stent restenosis (C-ISR) is unclear. We therefore sought to compare stroke/death/myocardial infarction (MI) rates between percutaneous interventions and nonoperative management for ≥50% C-ISR. Methods We performed a single-center retrospective review of consecutive patients presenting with ≥50% C-ISR to the vascular surgery service. Demographics, comorbidities, and intraoperative and postoperative variables were obtained. The degree of stenosis was verified by review of digital subtraction or computed tomography angiograms. The primary outcome was stroke/death/MI after the diagnosis of ≥50% C-ISR. χ2, Kruskal-Wallis, and Kaplan-Meier analysis was used to quantify outcomes of the patients treated percutaneously vs nonoperatively. Results During a 13-year period, 59 patients (75 C-ISRs) presented with ≥50% C-ISRs (n = 58 male [98%]; n = 57 C-ISRs asymptomatic [76%]) with a median age of 67.5 years (62.8-74.6). The initial pathologic process underlying the original stent was atherosclerosis in 33 (70%), radiation induced in 10 (21%), prior carotid endarterectomy in 4 (9%), and unknown in 28 (37%). Forty C-ISRs underwent a percutaneous intervention (19 percutaneous angioplasty only [48%]; 21 repeated stent and percutaneous angioplasty [52%]). Median follow-up for the entire cohort was 948 days (283-2322) and similar between the intervention and nonintervention arms. There were no significant differences between the arms with respect to age (P =.16), medical comorbidities (P >.05), original stent type (P =.46), or clopidogrel use (P =.74). At 30 days, there was one stroke and subsequent death in the intervention arm and none in the nonintervention arm. During the follow-up period, a median of 1.0 procedure was required to maintain patency. By Kaplan-Meier analysis, there were no statistically significant differences between the intervention and nonintervention arms with respect to stroke/death/MI as a composite or any of the individual components at last follow-up (P =.82). Kaplan-Meier estimated patency was not significantly superior in the intervention vs the nonintervention arm (8.0 years ± 1.1 vs 5.3 years ± 0.7; P =.14). Conclusions Over 13 years, percutaneous interventions for ≥50% C-ISR were safe and durable. However, interventions fail to improve long-term stroke/death/MI or patency rates relative to nonintervention. Intervention for C-ISR may not be necessary, although future appropriately powered, prospective trials will be necessary to confirm these findings and to determine the appropriateness of interventions for C-ISR.

UR - http://www.scopus.com/inward/record.url?scp=84994102512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994102512&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2016.05.086

DO - 10.1016/j.jvs.2016.05.086

M3 - Article

C2 - 27462003

AN - SCOPUS:84994102512

VL - 64

SP - 1286-1294.e1

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 5

ER -